Francois Venter talks about his unorthodox inaugural lecture, his work during the Aids crisis and his shoot-from-the-hip fix of our healthcare system ...

Individuals at risk for sexually acquired HIV have a new injectable option for preexposure prophylaxis (PrEP) with the US Food and Drug Administration’s (FDA’s) approval of lenacapavir ...

The Trump administration's plan to cut funding for HIV vaccine research comes at a time when the field is making substantial progress. Many effective treatments are available for HIV, but these ...

Researchers at the Department of Medicine, Huddinge, have presented new research on how some people with HIV can control the virus without treatment. The results show that gut bacteria and a ...

On May 30, a team of researchers funded by the National Institutes of Health got the word: Funding for their vaccine development program will end next year.

Human immunodeficiency virus (HIV) is a germ that causes a lifelong infection that slowly weakens the immune system. Though the infection is lifelong, medicines can keep the virus in check and ...

FA new injection to prevent HIV is expected to be approved by the U.S. Food and Drug Administration (FDA) later this month. If approved, the shot—lenacapavir—would be given twice a year and ...

Since the first case of HIV in the U.S. nearly 44 years ago, the country has made significant progress towards eradicating the disease. Now on the cusp of ending the epidemic, roadblocks from ...

Scientists found a way to make the HIV virus visible, potentially laying the groundwork for ways to banish it from the body altogether.

A new injection to prevent HIV is expected to be approved by the U.S. Food and Drug Administration later this month.

An estimated 39 million people around the world are living with HIV — and, while treatment options can ensure they have long, healthy lives, there is no known cure. Antiretroviral therapy (ART ...